Neuromodulation as a potential disease-modifying therapy for osteoarthritis

CJ Cruz, LS Dewberry, KJ Otto, KD Allen - Current Rheumatology Reports, 2023 - Springer
Abstract Purpose of Review The following review discusses the therapeutic potential of
targeting the autonomic nervous system (ANS) for osteoarthritis (OA) treatment and …

[HTML][HTML] Neuroimmune connections between corticotropin-releasing hormone and mast cells: Novel strategies for the treatment of neurodegenerative diseases

P Bhuiyan, YW Wang, HH Sha, HQ Dong… - Neural regeneration …, 2021 - journals.lww.com
Corticotropin-releasing hormone is a critical component of the hypothalamic–pituitary–
adrenal axis, which plays a major role in the body's immune response to stress. Mast cells …

[HTML][HTML] Endogenous oxytocin exerts anti-nociceptive and anti-inflammatory effects in rats

H Nishimura, M Yoshimura, M Shimizu… - Communications …, 2022 - nature.com
Oxytocin is involved in pain transmission, although the detailed mechanism is not fully
understood. Here, we generate a transgenic rat line that expresses human muscarinic …

[HTML][HTML] Changes of serum uric acid level during acute gout flare and related factors

J Zhang, W Sun, F Gao, J Lu, K Li, Y Xu, Y Li… - Frontiers in …, 2023 - frontiersin.org
Objective By studying the changes of serum uric acid (SUA) in acute stage and remission
stage of gouty arthritis, we aimed to explore the relationship between the changes of SUA …

[HTML][HTML] Upregulation of the hypothalamo-neurohypophysial system and activation of vasopressin neurones attenuates hyperalgesia in a neuropathic pain model rat

K Baba, M Kawasaki, H Nishimura, H Suzuki… - Scientific Reports, 2022 - nature.com
Arginine vasopressin (AVP) is a hypothalamic neurosecretory hormone well known as an
antidiuretic, and recently reported to be involved in pain modulation. The expression kinetics …

[HTML][HTML] Ursolic acid inhibits NF-κB signaling and attenuates MMP-9/TIMP-1 in progressive osteoarthritis: a network pharmacology-based analysis

EM Zahran, SA Mohamad, MM Elsayed, M Hisham… - RSC …, 2024 - pubs.rsc.org
Osteoarthritis (OA) is a degenerative joint disease, characterized by infiltration of monocytes
into the synovial joint which promotes inflammation, stiffness, joint swelling, cartilage …

[HTML][HTML] Soluble CCR2 gene therapy controls joint inflammation, cartilage damage, and the progression of osteoarthritis by targeting MCP-1 in a monosodium …

HS Na, SY Lee, DH Lee, JS Woo, SY Choi… - Journal of Translational …, 2022 - Springer
Background Osteoarthritis (OA) is the most common type of degenerative arthritis and affects
the entire joint, causing pain, joint inflammation, and cartilage damage. Various risk factors …

Pain Modulation by Oxytocin

M Kawasaki, A Sakai, Y Ueta - Peptides, 2024 - Elsevier
Oxytocin (OXT) was discovered in 1906 as a substance that promotes the pregnancy and
childbirth. It affects uterine contraction and lactation. Furthermore, as one of its physiological …

The neurohypophysial oxytocin and arginine vasopressin system is activated in a knee osteoarthritis rat model

H Nishimura, M Kawasaki, H Suzuki… - Journal of …, 2020 - Wiley Online Library
Osteoarthritis (OA) causes chronic joint pain and significantly impacts daily activities. Hence,
developing novel treatment options for OA has become an increasingly important area of …

Transgenic approaches to opening up new fields of vasopressin and oxytocin research

Y Ueta - Journal of Neuroendocrinology, 2021 - Wiley Online Library
Transgenic approaches have been applied to generate transgenic rats that express
exogenous genes in arginine vasopressin (AVP)‐and oxytocin (OXT)‐producing …